These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21637923)

  • 1. Down-regulation of β-N-acetyl-D-glucosaminidase increases Akt1 activity in thyroid anaplastic cancer cells.
    Krześlak A; Jóźwiak P; Lipińska A
    Oncol Rep; 2011 Sep; 26(3):743-9. PubMed ID: 21637923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
    Park SY; Ryu J; Lee W
    Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.
    Lee JE; Park JH; Moon PG; Baek MC
    Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation-inducing treatments inhibit estrogen receptor α expression and confer resistance to 4-OH-tamoxifen in human breast cancer-derived MCF-7 cells.
    Kanwal S; Fardini Y; Pagesy P; N'tumba-Byn T; Pierre-Eugène C; Masson E; Hampe C; Issad T
    PLoS One; 2013; 8(7):e69150. PubMed ID: 23935944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.
    Gandy JC; Rountree AE; Bijur GN
    FEBS Lett; 2006 May; 580(13):3051-8. PubMed ID: 16684529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the O-GlcNAc modification on insulin resistance and endoplasmic reticulum stress in 3T3-L1 cells.
    Sermikli BP; Aydogdu G; Yilmaz E
    Mol Biol Rep; 2020 Aug; 47(8):5927-5942. PubMed ID: 32691273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.
    Zhang P; Wang C; Ma T; You S
    Onco Targets Ther; 2015; 8():3305-13. PubMed ID: 26635480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1/2 phosphorylation and by down-regulation of cyclin-D1.
    Di Desidero T; Fioravanti A; Orlandi P; Canu B; Giannini R; Borrelli N; Man S; Xu P; Fontanini G; Basolo F; Kerbel RS; Francia G; Danesi R; Bocci G
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1465-73. PubMed ID: 23969186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP).
    Jacobsen KT; Iverfeldt K
    Biochem Biophys Res Commun; 2011 Jan; 404(3):882-6. PubMed ID: 21182826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
    Arias EB; Kim J; Cartee GD
    Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a specific inhibitor of nOGA - a caspase-3 cleaved O-GlcNAcase variant during apoptosis.
    Li J; Li Z; Li T; Lin L; Zhang Y; Guo L; Xu Y; Zhao W; Wang P
    Biochemistry (Mosc); 2012 Feb; 77(2):194-200. PubMed ID: 22348480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
    Gao Y; Parker GJ; Hart GW
    Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells.
    Mehdy A; Morelle W; Rosnoblet C; Legrand D; Lefebvre T; Duvet S; Foulquier F
    J Biochem; 2012 Apr; 151(4):439-46. PubMed ID: 22337894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intracellular fate of zonula occludens 2 is regulated by the phosphorylation of SR repeats and the phosphorylation/O-GlcNAcylation of S257.
    Quiros M; Alarcón L; Ponce A; Giannakouros T; González-Mariscal L
    Mol Biol Cell; 2013 Aug; 24(16):2528-43. PubMed ID: 23804652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique hexosaminidase reduces metabolic survival signal and sensitizes cardiac myocytes to hypoxia/reoxygenation injury.
    Ngoh GA; Facundo HT; Hamid T; Dillmann W; Zachara NE; Jones SP
    Circ Res; 2009 Jan; 104(1):41-9. PubMed ID: 19023128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantum mechanics/molecular mechanics study of the protein-ligand interaction of two potent inhibitors of human O-GlcNAcase: PUGNAc and NAG-thiazoline.
    Lameira J; Alves CN; Moliner V; Martí S; Kanaan N; Tuñón I
    J Phys Chem B; 2008 Nov; 112(45):14260-6. PubMed ID: 18939790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAcylation promotes non-amyloidogenic processing of amyloid-β protein precursor via inhibition of endocytosis from the plasma membrane.
    Chun YS; Park Y; Oh HG; Kim TW; Yang HO; Park MK; Chung S
    J Alzheimers Dis; 2015; 44(1):261-75. PubMed ID: 25208619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.